Clinical Trial Update: Myotubular Myopathy Genetic Testing Study

View source ↗

Summary

Cure CMD's genetic testing study for myotubular myopathy (NCT01817946) has completed. The update does not indicate a new drug approval or safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotubular Myopathy

Snippet

Sponsor: Cure CMD | Conditions: Myotubular Myopathy | Status: COMPLETED